• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Vaccination, Therapeutics & Diagnostics

Rashmi NSH by Rashmi NSH
3 years ago
in Healthcare & Medicine, Pharmaceutical & Chemical, Science News
1
AMR Vaccination by Dr. K I Varaprasad Reddy | Neo science Hub

AMR Vaccination by Dr. K I Varaprasad Reddy | Neo science Hub

Varaprasad Reddy’s Three-Pronged Vaccination Strategy on AMR

How do you view the challenge of Antimicrobial Resistance (AMR) in the context of past and current global health battles?

 AMR is an inevitable new challenge for humanity, much like the diseases we’ve faced and overcome in the past, including smallpox, plague, and more recently, COVID-19. The cycle of emerging viruses and the development of vaccines to combat them is ongoing. However, the real emerging threat now lies in bacterial infections. Our past successes give us hope that we can tackle this challenge too, with a keen understanding and adaptability to the evolving landscape of infectious diseases.

 Can you outline your proposed approach to combating AMR?

Certainly. The fight against AMR should be based on a three-pronged strategy: Vaccination, Therapeutics, and Diagnostics. In therapeutics, we’re looking at using nanotechnology for precise drug delivery and exploring immunomodulators to regulate the immune system. Monoclonal antibodies are also promising, as they are target-specific and attack only the affected cells. In diagnostics, nanotechnology plays a crucial role in enhancing accuracy and efficiency, allowing for early detection and point-of-care testing. These strategies, when combined, form a comprehensive approach to effectively combat AMR.

What are your thoughts on the current state of Research and Development (R&D) in India, especially in relation to AMR?

The R&D landscape in India, especially compared to other countries, is concerning. Unlike in many countries where R&D begins in universities and is then scaled up by the industry, Indian universities are not contributing to industrial R&D. The funding for R&D in India is disproportionately low compared to countries like the US. This scarcity of funding, ignorance of the policymakers and incentives dissuades private players from embarking on R&D projects.
Initially, product patents had no procedural restrictions, akin to baking a cake with different methods. This flexibility enabled their company to produce a vaccine affordable to the common man. However, the introduction of the GATT-TRIPs agreement, which according to him, purely a political move, transformed patent rules, restricting the scope of human innovation. The shift from ‘Product Patenting’ to ‘Process Patenting’ has limited the scope of human innovation, which could potentially impact the fight against AMR.

In light of these challenges, what opportunities do you see for combating AMR?

Despite these challenges, AMR presents a potential opportunity. I urge companies to focus on innovative solutions like Immuno modulation, Zerome sequencing, and Bio-sensors. Considering India’s leadership in vaccine production, we have a model for success that can be replicated in the fight against AMR. It’s crucial for major players to step forward in this battle, much like India’s triumph in vaccine production.

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: AMRfeaturedhealthcaresciencenewsTherapeutics & DiagnosticsVaccination
Rashmi NSH

Rashmi NSH

Other Posts

Young maize in paired rows on raised beds with water in the furrows between them

Lifting the Crop Off the Floor: Why Raised Beds Are Gaining Ground in a Water-Short Country

November 15, 2026 - Updated on November 16, 2026
4
Trays of green and purple microgreens beside a field being sprayed

Small Leaves, Small Particles: Microgreens Have the Evidence. Nano-Urea Is Still Earning It

November 15, 2026 - Updated on November 16, 2026
4

A Crore and a Half Recharge Pits Later: What India’s Water Reforms Can, and Cannot, Teach the Global South

A Purple Broccoli That Seeds in Delhi and a Sponge Gourd That Shrugs Off a Virus

Fourteen Seconds to 241 km/h and Back: What a Runway Test Says About Where Car Performance Now Lives

An Aeroplane on a Helipad: What Electra’s Manhattan Landing Proves, and What It Does Not

After the Space Station: NASA Opens the Contest to Become a Tenant in Orbit

At 94, the Air Force Counts Its Squadrons, and Waits for an Engine India Can Call Its Own

Next Post
GV Prasad

"Misuse, Environment, Investment"

Please login to join discussion

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
8

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist